Bladder Cancer Canada

4936 Yonge Street, Suite 1000
Toronto, ON M2N 6S3
Executive Director: Tammy Northam
Board Chair: Ferg Devins

Charitable Reg. #:83612 6060 RR001

STAR RATING

Ci's Star Rating is calculated based on the following independent metrics:

[Charity Rating: 4/4]

✔+

FINANCIAL TRANSPARENCY

Audited financial statements for current and previous years available on the charity’s website.

B

RESULTS REPORTING

Grade based on the charity's public reporting of the work it does and the results it achieves.

n/r

DEMONSTRATED IMPACT

The demonstrated impact per dollar Ci calculates from available program information.

NEED FOR FUNDING

Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.

85%

CENTS TO THE CAUSE

For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 85 cents are available for programs.



My anchor

Programs

About Bladder Cancer Canada:

Bladder Cancer Canada (BCC) was founded in 2009 by two Canadians who were diagnosed with bladder cancer and wanted to improve the level of support available for those diagnosed with the disease. BCC reports that 9,000 Canadians will be diagnosed with bladder cancer annually. It is the fifth most common cancer in the country but is highly underfunded, ranking 21st out of the top 25 cancers in terms of research funding (according the BCC). Due to a high recurrence rate of 60-70%, bladder cancer is also the most expensive cancer type to treat on a per-patient basis.

Bladder Cancer Canada’s mission is three-fold: support bladder cancer patients; increase awareness and education regarding the disease; and fund and promote bladder cancer research. These pillars align with the charity’s three program areas: patient support and education, awareness, and research.

Bladder Cancer Canada spent $743k on programs and research funding in F2018: 30% for awareness, 29% for research, and 12% for patient support and education (unallocated payroll accounts for the remaining 29%). To increase awareness, BCC works with patients, doctors, and the general public. It distributed 22,500 pieces of literature and 11,000 guidebooks to doctors in F2018, and reached 250 medical offices and hospitals. BCC also has 2,354 Twitter followers and estimates that when their followers are considered, its potential reach is 9.9 million.

For patient support and education, BCC posts online resources, hosts meetings and webinars, runs an online discussion forum, and also provides one-to-one support through its One2One program. BCC reports that it had 205,627 website visitors in F2018 (up 66% from F2017) and 1,800 forum members, reached 750 people at meetings or webinars, and helped 175 people though One2One.

Bladder Cancer Canada is a major sponsor of the Canadian Bladder Cancer Information System (CBCIS) initiative, which launched in F2014. CBCIS is a database that collects treatment outcome data on bladder cancer patients from 14 health centers across Canada. The goal is to use this data to improve treatment and clinical management practices for bladder cancer patients. Data from over 3,000 patients has been entered into the database as of F2018. BCC also co-funds various research projects in partnership with Canadian Urology Oncology group, Cancer Research Society, and Canadian Urological Association Scholarship Foundation.

BCC distributes an annual $50,000 standalone grant for basic bladder cancer research. The grant recipient team for F2018 was Dr. Black (University of British Columbia), Dr. Morin (Head of Proteomics at BC Cancer Genome Sciences Center), and their researchers. Their project studies potential mechanisms of chemotherapy resistance in metastatic bladder cancer. To celebrate its tenth anniversary in F2019, BCC doubled its standalone grants (from one to two). F2019 recipients were: Dr. Kassouf at McGill University, who is studying combination therapy options for patients negatively affected by current treatment methods; and Dr. Kulkarni (University of Toronto) and Dr. Breau (University of Ottawa), who are studying a rare form of urothelial cancer that affects the lining of the kidney and ureter. 

My anchor

Results and Impact

In F2014, Bladder Cancer Canada partnered with Canadian Urologic Oncology Group and Canadian Urological Association to run an annual Quality of Care in Bladder Cancer Meeting. In BCC’s F2018 impact report, it states that as a result of the four meetings that occurred between F2014 and F2018, a white paper has been developed titled ‘Standards of Care for Bladder Cancer.’  The document outlines 60 quality of care indicators that can be used in bladder cancer management.

My anchor

Finances

Bladder Cancer Canada is a small charity that received $973k in donations in F2018. Administrative costs are 8% of revenue (excluding investment income) and fundraising costs are 7% of donations. Per dollar donated, 85 cents go to the cause, which is within Ci’s reasonable range for overhead spending.

Funding reserves of $904k can cover annual program spending and grants (which reflect amounts contributed to the CBCIS project) at the F2018 level for 1.2 years.

This is a new charity report that has been sent to Bladder Cancer Canada for review. Comments and edits may be forthcoming.

Created on August 20, 2019 by Katie Khodawandi.

Financial Review


Financial Ratios

Fiscal year ending December
201820172016
Administrative costs as % of revenues 7.6%6.5%6.5%
Fundraising costs as % of donations 7.1%6.9%9.9%
Total overhead spending 14.7%13.4%16.4%
Program cost coverage (%) 121.7%110.9%124.4%

Summary Financial Statements

All figures in $s
201820172016
Donations 972,678835,874842,201
Government funding 03,3950
Investment income 17,3132,5974,042
Total revenues 989,991841,866846,243
Program costs 649,377647,524518,339
Grants 93,19750,00084,259
Administrative costs 73,77254,69854,708
Fundraising costs 68,97857,60883,028
Total spending 885,324809,830740,334
Cash flow from operations 104,66732,036105,909
Capital spending 000
Funding reserves 903,948773,302749,341

Note: All contributions made by BCC to the CBCIS project are included in grants. Ci did not include CBCIS fund cash in F2017 or F2016 funding reserves due to a change in accounting policy in F2018, indicating that BCC does not have significant influence over the project. Loss on disposal of investments is non-cash and thus not reported as an expenses in Ci’s analysis, lowering total expenses by $10k in F2018. The charity's audited financials report no capital spending. 

Salary Information

Full-time staff: 1

Avg. Compensation $72,087

Top 10 staff salary range

$350k +
0
$300k - $350k
0
$250k - $300k
0
$200k - $250k
0
$160k - $200k
0
$120k - $160k
0
$80k - $120k
0
$40k - $80k
1
< $40k
0

Information from most recent CRA Charities Directorate filings for F2017

My anchor

Comments & Contact

Comments added by the Charity:

No comments have been added by charity

Charity Contact

Website: www.bladdercancercanada.org
This email address is being protected from spambots. You need JavaScript enabled to view it.

Print